Narcissist's Beloved Paranoia Bipolar Disorder Education Program - Bipolar Education Program - Bipolar disorder. Diagnosing Bipolar Disorder Module 1: Diagnosing Bipolar Disorder Presented by: Professor Gordon Parker Professor Gordon Parker is Scientia Professor at the School of Psychiatry, University of New South Wales, and the founder of the Black Dog Institute.
He has a keen commitment to advancing research into the mood disorders and, in particular, to improving their classification, detection and management. He has written a number of books, including 'Dealing with Depression: A Common Sense Guide to Mood Disorders'. Print version - Diagnosing Bipolar Disorder [PDF, 187KB] The causes of Bipolar Disorder Module 2: The causes of Bipolar Disorder Presented by: Professor Gin Malhi Professor Gin Malhi is Chair of Psychological Medicine at the University of Sydney and consultant psychiatrist at the Black Dog Institute. Print version - The causes of Bipolar Disorder [PDF, 394KB] Staying well with a stay well plan Module 5: Staying well with a stay well plan Presented by: Dr Sarah Russell Issues for carers. Crazy Meds: The Good, The Bad, & The Funny of Psych Meds - MedClass - SSRI Poop-Out / Tachyphylaxis & Dosage Equivalents.
Antidepressant Topic Index ‹ SSRI discontinuation syndrome. | SSRI Overview and Topic Index 1.
What is SSRI & SNRI Poop-Out / Tachyphylaxis Serotonin-Selective Reuptake Inhibitor Antidepressant Tachyphylaxis, in fancy doctor-speak, better known as SSRI poop-out, is when an SSRI that has been working for you, suddenly stops working and still doesn’t work no matter how much more you take. While this can happen to any medication, crazy or not, reuptake inhibitors in general and serotonin-selective reuptake inhibitors in particular, as a class are more susceptible to it; although individual drugs like Remeron or Gabitril might be failing as frequently as, if not more often than SSRIs.1 It also happens with Serotonin & Norepinephrine Reuptake Inhibitors (SNRIs), but nowhere near as often. I’ve included them here because SNRIs are often a good substitute for SSRIs, especially if SSRIs work well for someone but keep pooping out. 2. That depends. And it’s not just people with unipolar depression: Schizophrenia Research : Depressive symptom patterns in patients with chronic schizophrenia and subsyndromal depression.
Abstract Background Since subsyndromal depressive symptoms (SDS) are prevalent, under-recognized and clinically important problems in patients with schizophrenia, as well as in the elderly, the association and correlates of SDS in mid-life and older age patients with schizophrenia deserves more investigation.
The purpose of this study is to learn more about the occurrence, pattern of symptoms and associated features of subsyndromal depressive symptoms in patients with chronic schizophrenia or schizoaffective disorder. Method The first 165 participants from the “Citalopram Augmentation in Older Adults with Psychoses” (NIH RO1 # 63931) study comprised the sample. Results Conclusion This study confirms the high prevalence of depressive symptoms in middle-aged and older persons with schizophrenia and schizoaffective disorder who were selected on the basis of having subsyndromal symptoms of depression. Keywords Copyright © 2006 Elsevier B.V. Treating bipolar: the evidence - Medical Observer. THE ongoing management of bipolar disorder in primary care is now recognised as an essential part of treatment for this significant mental disorder that has a lifetime prevalence of 1.2% and is linked to around 12% of all Australian suicides.1 The latest Royal Australian and New Zealand College of Psychiatrists clinical guidelines include the option for using atypical antipsychotics for maintenance therapy in bipolar disorder.2 Several antipsychotics are indicated for maintenance treatment in bipolar disorder in Australia, including aripiprazole, risperidone and quetiapine fumarate.
But debate is emerging around whether sufficient evidence exists to support the use of these drugs in longer-term maintenance treatment. A recently published literature review in PLoS Medicine3 found most citations supporting the use of second-generation antipsychotic aripiprazole (Abilify) in maintenance therapy referred back to just one double-blind, randomised controlled trial.4,5 Long-term maintenance 1.